Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Venous Thromboembolism Risk in Cancer Patients Receiving First-Line Immune Checkpoint Inhibitor Vs. Chemotherapy

Sarah B May, Jennifer La, Emily Milner, Nimrah Riaz, Christopher I Amos, David A. Garcia, Marc Carrier, Neil Zakai, Nhan V Do, Mary Brophy, Vipul Chitalia, J. Michael Gaziano, Nathanael Fillmore, Ang Li

Blood (2022) 140 (Supplement 1): 7968–7970.

https://doi.org/10.1182/blood-2022-162658

Published: 2022

Journal Articles

Derivation and External Validation of Clinical Risk Assessment Model for Cancer Associated Thrombosis in Two Unique U.S. Healthcare Systems

Ang Li, Jennifer La, Sarah B May, Danielle Guffey, Wilson L Da Costa, Jr., Christopher I Amos, Emily Milner, Raka Bandyo, Carolina Granada, Nimrah Riaz, Nhan V Do, Mary Brophy, Vipul Chitalia, J. Michael Gaziano, David A. Garcia, Marc Carrier, Christopher R. Flowers, Neil Zakai, Nathanael Fillmore

Blood (2022) 140 (Supplement 1): 5637–5639.

https://doi.org/10.1182/blood-2022-160017

Published: 2022

Journal Articles

Patients with B Cell Malignancy That Lacked Immune Response to Sars-Covid-2 Vaccination Mount Antibody Response Following Actual Sars-Covid-2 Infection: Potential to Improve Vaccination Strategy

Hamza Hassan, June Corrigan, Nathanael R Fillmore, Jennifer La, Nhan V Do, Mary Brophy, Nikhil C Munshi

Blood (2022) 140 (Supplement 1): 12587–12588.

https://doi.org/10.1182/blood-2022-170811

Published: 2022

Journal Articles

Increased COVID-19 Breakthrough Infection Risk after Sars-Cov-2 Vaccine Boosting in Patients with Plasma Cell Disorders: A Large Nationwide Veterans Affairs Study

Nathanael R Fillmore, Jennifer La, Julie Tsu-Yu Wu, Westyn Branch-Elliman, Paul Monach, Mary Brophy, Nhan V Do, Nikhil C Munshi

Blood (2022) 140 (Supplement 1): 4297–4298.

https://doi.org/10.1182/blood-2022-169559

Published: 2022

Journal Articles

Baseline Correlates of Frailty and Its Association with Survival in U.S. Veterans with Newly Diagnosed and Treated Acute Myeloid Leukemia

Michelle Hyunju Lee, Jennifer La, Mary Brophy, Nhan V Do, Jane A. Driver, David P Tuck, Nathanael R Fillmore, Clark Dumontier

Blood (2022) 140 (Supplement 1): 8117–8118.

https://doi.org/10.1182/blood-2022-169225

Published: 2022

Journal Articles

Increased COVID-19 breakthrough infection risk in patients with plasma cell disorders

Jennifer La, Julie Tsu-Yu Wu, Westyn Branch-Elliman, Linden Huhmann, Summer S. Han, Mary Brophy, Nhan V. Do, Albert Y. Lin, Nathanael R. Fillmore, Nikhil C. Munshi

Blood (2022) 140 (7): 782–785.

https://doi.org/10.1182/blood.2022016317

Published: 2022

Journal Articles

Inadequate Sars-Cov-2 Vaccine Effectiveness in Patients with Multiple Myeloma: A Large Nationwide Veterans Affairs Study

Nathanael R Fillmore, Jennifer La, Julie Tsu-Yu Wu, Westyn Branch-Elliman, Linden Huhmann, Summer S Han, Giovanni Parmigiani, David P Tuck, Mary Brophy, Nhan V Do, Albert Y Lin, Nikhil C. Munshi

Blood (2021) 138 (Supplement 1): 400.

https://doi.org/10.1182/blood-2021-154323

Published: 2021

Journal Articles

Incidence of Second Primary Malignancies and Association with Treatment in US Veterans with Multiple Myeloma

Nathanael Fillmore, PhD, Sarvari Venkata Yellapragada, MD, Cenk Yildirim, MS, Aimaz Afrough, MD, Adanma Anji Ayanambakkam Attanathi, MD, Ifeorah Chizoba, MPH, Nhan Do, MD, Mary Brophy, MD MPH, Nikhil C. Munshi, MD

Blood (2019) 134 (Supplement_1): 1806.

https://doi.org/10.1182/blood-2019-132227

Published: 2019

Journal Articles

With Equal Access, African Americans with Non-del17p Multiple Myeloma Have Superior Overall Survival, but del17p Still Carries Poor Prognosis across Race: A VA Study

Anusha Munjuluri, MSc, Nathanael Fillmore, PhD, Diana Cirstea, MD, Hassan Yameen, MD, Sarvari Venkata Yellapragada, MD, Ifeorah Chizoba, MPH, Nhan Do, MD, Mary Brophy, MD MPH, Nikhil C. Munshi, MD

Blood (2019) 134 (Supplement_1): 4388.

https://doi.org/10.1182/blood-2019-131247

Published: 2019

Journal Articles

With equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study

Nathanael R. Fillmore, Sarvari V. Yellapragada, Chizoba Ifeorah, Ansh Mehta, Diana Cirstea, Paul S. White, Gustavo Rivero, Andrew Zimolzak, Saiju Pyarajan, Nhan Do, Mary Brophy, Nikhil C. Munshi

Blood (2019) 133 (24): 2615–2618.

https://doi.org/10.1182/blood.2019000406

Published: 2019

Journal Articles

Black Patients Experience Highest Rates of Specific Cancer-Associated Venous Thromboembolism: A Study Based at a Large Safety-Net Hospital in New England

Nana Oduraa Addo-Tabiri, MD PhD, Rani Chudasama, MD, Rhythm Vasudeva, MBChB, Orly Leiva, MD, Brenda Garcia, MD, Jonathan Ravid, BS, Bunze Tamala, BS, Linda Rosen, MSEE, Mostafa Belghasem, MD PhD, Janice Weinberg, PhD, Ryan Ferguson, MPH, Brett Johnson, PhD, Mary Brophy, MD MPH, Vipul Chitalia, MD PhD

Blood (2018) 132 (Supplement 1): 496.

https://doi.org/10.1182/blood-2018-99-115605

Published: 2018

Journal Articles

With Equal Access and Utilization of Resources,Younger African American Patients Have Superior Survival Compared to Caucasian Patients Diagnosed with Multiple Myeloma at the Veterans Affairs Hospitals

Nathanael Fillmore, PhD, Sarvari Venkata Yellapragada, MD, Mehmet Kemal Samur, PhD, Gustavo A. Rivero, MD, Saiju Pyarajan, PhD, Nhan Do, MD, Mary Brophy, MD MPH, Nikhil Munshi, MD

Blood (2018) 132 (Supplement 1): 3191.

https://doi.org/10.1182/blood-2018-99-119490

Published: 2018

Journal Articles

Chronic Inflammation May Predispose to the Development of Plasma Cell Dyscrasias.

Elizabeth M. Blanchard, MD, Elizabeth Lawler, MPH, Mary Brophy, MD, MPH, Louis Fiore, MD, MPH, Nikhil C. Munshi, MD

Blood (2004) 104 (11): 3650.

https://doi.org/10.1182/blood.V104.11.3650.3650

Published: 2004

NARROW

Venous Thromboembolism Risk in Cancer Patients Receiving First-Line Immune Checkpoint Inhibitor Vs. Chemotherapy

Derivation and External Validation of Clinical Risk Assessment Model for Cancer Associated Thrombosis in Two Unique U.S. Healthcare Systems

Patients with B Cell Malignancy That Lacked Immune Response to Sars-Covid-2 Vaccination Mount Antibody Response Following Actual Sars-Covid-2 Infection: Potential to Improve Vaccination Strategy

Increased COVID-19 Breakthrough Infection Risk after Sars-Cov-2 Vaccine Boosting in Patients with Plasma Cell Disorders: A Large Nationwide Veterans Affairs Study

Baseline Correlates of Frailty and Its Association with Survival in U.S. Veterans with Newly Diagnosed and Treated Acute Myeloid Leukemia

Increased COVID-19 breakthrough infection risk in patients with plasma cell disorders

Inadequate Sars-Cov-2 Vaccine Effectiveness in Patients with Multiple Myeloma: A Large Nationwide Veterans Affairs Study

Incidence of Second Primary Malignancies and Association with Treatment in US Veterans with Multiple Myeloma

With Equal Access, African Americans with Non-del17p Multiple Myeloma Have Superior Overall Survival, but del17p Still Carries Poor Prognosis across Race: A VA Study

With equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study

Black Patients Experience Highest Rates of Specific Cancer-Associated Venous Thromboembolism: A Study Based at a Large Safety-Net Hospital in New England

With Equal Access and Utilization of Resources,Younger African American Patients Have Superior Survival Compared to Caucasian Patients Diagnosed with Multiple Myeloma at the Veterans Affairs Hospitals

Chronic Inflammation May Predispose to the Development of Plasma Cell Dyscrasias.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only